This finding establishes Lgals3bp as an endogenous TAK1 negative regulator in the colon, and based on the reference gene hypothesis, suggests that over-expression hsa_circ_000240 might serve as a potential therapeutic or critical role in colorectal cancer development by influencing TAK1-NF-κB signaling pathways. Here, LGALS3BP is linked to colorectal cancer.